Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Illumina Laboratory Services, |
RCV001270873 | SCV001451650 | likely pathogenic | Multiple epiphyseal dysplasia type 1 | 2019-04-26 | criteria provided, single submitter | clinical testing | The COMP c.1403G>C (p.Cys468Ser) variant is a missense variant. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. This variant is not reported in the Genome Aggregation Database in a region of good sequencing coverage, so the variant is presumed to be rare. Functional studies of the p.Cys468Ser variant have not been conducted, but it affects the seventh type 3 calcium-binding repeat. These repeats play an important role in protein function and are a common site of pathogenic variants, particularly missense variants (Briggs et al. 2002; Tan et al. 2009; Jackson et al. 2012). Cys468 also participates in a disulfide bond. Multiple in silico tools consistently predict a deleterious effect of the p.Cys468Ser variant, and another amino acid change at the same position has been reported as causative for pseudoachondroplasia (Hecht et al. 1995; Xie et al. 2013). Based on the collective evidence, the p.Cys468Ser variant is classified as likely pathogenic for multiple epiphyseal dysplasia. |